HIGHLIGHTS
- who: Lactate/Pyruvate Ratio and collaborators from the (UNIVERSITY) have published the research work: For Peer Review Only, in the Journal: Scientific Reports, 7(1): p. 1003. of /1003/
- what: The majority of past TBI clinical drug studies focused on more multifunctional global brain approaches to influences hormones and steroids, including corticosteroids , progesterone , citicoline , magnesium sulphate , and statins with limited success.
- future: The combination of metabolic and anti-inflammatory actions marks cyclosporine a very noteworthy dual-acting therapy for future studies. The prospect of using metabolic supplementation to ameliorate secondary injury including inflammation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.